Salerno Pharms Drug Patent Portfolio
Salerno Pharms owns 1 orange book drug protected by 2 US patents Given below is the list of Salerno Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9597289 | Liquid oral simvastatin compositions | 23 Feb, 2030 | Active |
| US10300041 | Liquid oral simvastatin compositions | 26 Apr, 2027 | Active |
Latest Legal Activities on Salerno Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Salerno Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 25 Oct, 2022 | US10300041 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 14 Sep, 2020 | US9597289 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 28 May, 2019 | US10300041 |
|
Recordation of Patent Grant Mailed
Critical
| 28 May, 2019 | US10300041 |
|
Email Notification
Critical
| 09 May, 2019 | US10300041 |
|
Issue Notification Mailed
Critical
| 08 May, 2019 | US10300041 |
| Dispatch to FDC | 09 Apr, 2019 | US10300041 |
|
Application Is Considered Ready for Issue
Critical
| 08 Apr, 2019 | US10300041 |
|
Issue Fee Payment Received
Critical
| 05 Apr, 2019 | US10300041 |
|
Issue Fee Payment Verified
Critical
| 05 Apr, 2019 | US10300041 |
|
Email Notification
Critical
| 11 Feb, 2019 | US10300041 |
| Filing Receipt - Corrected | 11 Feb, 2019 | US10300041 |
|
Electronic Review
Critical
| 09 Jan, 2019 | US10300041 |
|
Mail Notice of Allowance
Critical
| 09 Jan, 2019 | US10300041 |
|
Email Notification
Critical
| 09 Jan, 2019 | US10300041 |
Salerno Pharms's Family Patents
Salerno Pharms Drug List
Given below is the complete list of Salerno Pharms's drugs and the patents protecting them.
1. Flolipid
Flolipid is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9597289 | Liquid oral simvastatin compositions |
23 Feb, 2030
(5 years from now)
| Active |
| US10300041 | Liquid oral simvastatin compositions |
26 Apr, 2027
(2 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Flolipid's drug page